- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
ideaPoint Launches New Partnering-Opportunity Software
Anaqua’s ideaPoint has announced the launch of new software that "will simplify the identification and capture of key partnering opportunities and novel innovative ideas".
The software, ideaPoint 5.0, enables organizations to accelerate the speed and efficiency of evaluating, tracking, and managing innovation and identifying and capitalizing on opportunities for partnerships and collaborations, whether internal or external.
One of the reported key enhancements is Mobile Scout, which enables users to capitalize on potential partnering opportunities more easily and effectively through a mobile device or tablet. Users can quickly capture meetings with potential partners and tag their entries with key information. They can turn meeting notes into opportunities with one click or set reminders to keep track of potential opportunities. In addition, they can easily report on the ROI of events based on leads generated to determine the best way to allocate future resources.
ideaPoint will be presenting the new software at BioEurope on November 5 –7 and participating in the Innovation Roundtable Nov 6– 8, both in Copenhagen, Denmark.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
